Literature DB >> 8815155

Neuromuscular complications in the ICU: the spectrum of critical illness-related conditions causing muscular weakness and weaning failure.

E F Hund1.   

Abstract

Muscular weakness and atrophy in intensive care patients has long been attributed to a combination of immobilization and cataboly. More recently, it has become apparent that specific injuries to the peripheral nerve, the neuromuscular junction and the muscle are more likely causes of weakness in these patients. Clinically, delayed weaning from the ventilator and prolonged neurologic rehabilitation are the most important consequences. Detailed electrodiagnostic examination is necessary for accurate diagnosis. In selected patients, a combined muscle and nerve biopsy is helpful. In this review, I describe the current knowledge of neuromuscular complications in patients with long-term treatment in the intensive care unit.

Entities:  

Mesh:

Year:  1996        PMID: 8815155     DOI: 10.1016/0022-510x(95)00310-x

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  5 in total

Review 1.  Diagnosis of acute neuropathies.

Authors:  Clarissa Crone; Christian Krarup
Journal:  J Neurol       Date:  2007-09-21       Impact factor: 4.849

2.  Two identical episodes of acute quadriparesia in an intensive care unit patient.

Authors:  A Kohler; P Jolliet; H Schnorf; M R Magistris
Journal:  Intensive Care Med       Date:  1998-08       Impact factor: 17.440

3.  Risk factors for critical illness polyneuromyopathy.

Authors:  J Bednarík; P Vondracek; L Dusek; E Moravcova; I Cundrle
Journal:  J Neurol       Date:  2005-03-30       Impact factor: 4.849

4.  Somatosensory evoked potentials as predictor of systemic inflammatory response syndrome in pigs?

Authors:  Henning Ohnesorge; Petra Bischoff; Jens Scholz; Enno Yekebas; Jochen Schulte am Esch
Journal:  Intensive Care Med       Date:  2003-02-08       Impact factor: 17.440

Review 5.  Approach to neuromuscular disorders in the intensive care unit.

Authors:  Kenneth C Gorson
Journal:  Neurocrit Care       Date:  2005       Impact factor: 3.210

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.